Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation.

Girnita DM, Webber SA, Zeevi A.

Clin Lab Med. 2008 Sep;28(3):423-40, vi. doi: 10.1016/j.cll.2008.08.002. Review.

PMID:
19028261
2.

Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study.

Girnita DM, Brooks MM, Webber SA, Burckart GJ, Ferrell R, Zdanowicz G, DeCroo S, Smith L, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Ranganathan S, Naftel D, Girnita AL, Zeevi A.

Transplantation. 2008 Jun 15;85(11):1632-9. doi: 10.1097/TP.0b013e3181722edc.

PMID:
18551071
3.

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?

Dickinson AM, Harrold JL, Cullup H.

Expert Rev Mol Med. 2007 Nov 2;9(29):1-19. Review.

PMID:
17976248
4.

Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.

Nowacki TM, Kuerten S, Zhang W, Shive CL, Kreher CR, Boehm BO, Lehmann PV, Tary-Lehmann M.

Cell Immunol. 2007 May;247(1):36-48. Epub 2007 Sep 7.

5.

New approaches for monitoring CTL activity in clinical trials.

Malyguine A, Strobl S, Zaritskaya L, Baseler M, Shafer-Weaver K.

Adv Exp Med Biol. 2007;601:273-84. Review.

PMID:
17713015
6.

VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome.

Günesacar R, Opelz G, Erken E, Pelzl S, Döhler B, Ruhenstroth A, Süsal C.

Hum Immunol. 2007 Jul;68(7):599-602. Epub 2007 Apr 18.

PMID:
17584582
7.

Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients.

Girnita DM, Webber SA, Ferrell R, Burckart GJ, Brooks MM, McDade KK, Chinnock R, Canter C, Addonizio L, Bernstein D, Kirklin JK, Girnita AL, Zeevi A.

Transplantation. 2006 Dec 27;82(12):1774-80.

PMID:
17198275
8.

Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts.

Veale JL, Liang LW, Zhang Q, Gjertson DW, Du Z, Bloomquist EW, Jia J, Qian L, Wilkinson AH, Danovitch GM, Pham PT, Rosenthal JT, Lassman CR, Braun J, Reed EF, Gritsch HA.

Hum Immunol. 2006 Oct;67(10):777-86. Epub 2006 Aug 4.

PMID:
17055354
9.

Correlation of genetic markers of rejection with biopsy findings following human pancreas transplant.

Cashion A, Sabek O, Driscoll C, Gaber L, Kotb M, Gaber O.

Clin Transplant. 2006 Jan-Feb;20(1):106-12.

PMID:
16556164
10.

Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients.

Corti B, Altimari A, Gabusi E, Pinna AD, Lauro A, Morselli-Labate AM, Gruppioni E, Pirini MG, Fiorentino M, Ridolfi L, Grigioni WF, D'Errico-Grigioni A.

Transplant Proc. 2005 Dec;37(10):4467-71.

PMID:
16387147
11.

Standardization and validation issues of the ELISPOT assay.

Janetzki S, Cox JH, Oden N, Ferrari G.

Methods Mol Biol. 2005;302:51-86.

PMID:
15937345
12.

Granzyme B ELISPOT assay determines the cytotoxic T lymphocyte precursor frequency after HLA-identical living-related kidney transplantation.

Gerrits JH, van de Wetering J, Ijzermans JN, Weimar W, van Besouw NM.

Transplant Proc. 2005 Mar;37(2):752-4.

PMID:
15848521
13.

High frequency of QPY allele and linkage disequilibrium of granzyme-B in Epstein-Barr-virus-associated hemophagocytic lymphohistiocytosis.

Zaitsu M, Yamamoto K, Ishii E, Teramura T, Nakadate N, Sako M, Sakata N, Wakiguchi H, Hirose M, Imayoshi M, Ogata Y, Imashuku S, Hamasaki Y, Yasukawa M.

Tissue Antigens. 2004 Nov;64(5):611-5.

PMID:
15496206
14.

Fas/FasL and perforin/granzyme pathway in acute rejection and diffuse alveolar damage after allogeneic lung transplantation-a human biopsy study.

Bittmann I, Müller C, Behr J, Groetzner J, Frey L, Löhrs U.

Virchows Arch. 2004 Oct;445(4):375-81. Epub 2004 Jul 29.

PMID:
15480769
15.

Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease.

Densem CG, Hutchinson IV, Yonan N, Brooks NH.

Transpl Immunol. 2004 Nov;13(3):211-7.

PMID:
15381204
16.

Granzyme B encoded by the commonly occurring human RAH allele retains pro-apoptotic activity.

Sun J, Bird CH, Thia KY, Matthews AY, Trapani JA, Bird PI.

J Biol Chem. 2004 Apr 23;279(17):16907-11. Epub 2004 Jan 29.

17.

[Levels of granzyme B, perforin and Fas ligand antigens and mRNAs in patients following allogeneic hematopoietic stem cell transplantation].

Takahashi A, Horie O, Murayama T, Ryo R, Saigo K.

Rinsho Byori. 2003 Dec;51(12):1167-73. Japanese.

PMID:
14743738
18.

Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation.

D'Errico A, Corti B, Pinna AD, Altimari A, Gruppioni E, Gabusi E, Fiorentino M, Bagni A, Grigioni WF.

Transplant Proc. 2003 Dec;35(8):3061-5.

PMID:
14697980
19.

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity.

Shafer-Weaver K, Sayers T, Strobl S, Derby E, Ulderich T, Baseler M, Malyguine A.

J Transl Med. 2003 Dec 29;1(1):14.

20.

Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.

Karlsson AC, Martin JN, Younger SR, Bredt BM, Epling L, Ronquillo R, Varma A, Deeks SG, McCune JM, Nixon DF, Sinclair E.

J Immunol Methods. 2003 Dec;283(1-2):141-53.

PMID:
14659906

Supplemental Content

Support Center